Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial monoamine oxidase refers to a class of flavin-containing oxidative enzymes found in some bacterial species, which catalyze the breakdown of primary and secondary amines, including monoamines and polyamines, by oxidative deamination. While similar in broad enzymatic function to human MAO-A and MAO-B, bacterial MAOs are generally soluble (not membrane-bound), can display thermostability, and exhibit diverse substrate specificity. Structurally, they share a conserved flavin adenine dinucleotide (FAD)-binding site with eukaryotic MAOs, but vary in their sequence, substrate access, and active site architecture. Their physiological roles in bacteria are not fully understood but likely relate to nitrogen metabolism or catabolism of amine compounds. Unlike human MAOs, bacterial versions are not recognized as therapeutic drug targets, although engineered versions may be used as biocatalysts in chemical synthesis or biosensing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monoamine oxidase (bacterial).